All University Hospitals Cleveland Medical Center articles
-
NewsResearchers to test a gut microbiome intervention as part of a cancer therapy regimen
A phase III clinical trial will test a gut microbiome intervention as part of a kidney cancer therapy regimen. The investigational agent is a once-daily capsule requiring no refrigeration or special handling.